The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Exjade is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
The global Exjade market was valued at US$ 323 million in 2023 and is anticipated to reach US$ 113.8 million by 2030, witnessing a CAGR of -5.7% during the forecast period 2024-2030.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
This report aims to provide a comprehensive presentation of the global market for Exjade, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exjade.
Report Scope
The Exjade market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exjade market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exjade manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
125mg
250mg
500mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Exjade manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Exjade in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Exjade is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
The global Exjade market was valued at US$ 323 million in 2023 and is anticipated to reach US$ 113.8 million by 2030, witnessing a CAGR of -5.7% during the forecast period 2024-2030.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
This report aims to provide a comprehensive presentation of the global market for Exjade, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exjade.
Report Scope
The Exjade market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exjade market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exjade manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
125mg
250mg
500mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Exjade manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Exjade in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Exjade Market Overview
1.1 Product Overview and Scope of Exjade
1.2 Exjade Segment by Type
1.2.1 Global Exjade Market Value Comparison by Type (2024-2030)
1.2.2 125mg
1.2.3 250mg
1.2.4 500mg
1.3 Exjade Segment by Application
1.3.1 Global Exjade Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Exjade Market Size Estimates and Forecasts
1.4.1 Global Exjade Revenue 2019-2030
1.4.2 Global Exjade Sales 2019-2030
1.4.3 Global Exjade Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Exjade Market Competition by Manufacturers
2.1 Global Exjade Sales Market Share by Manufacturers (2019-2024)
2.2 Global Exjade Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Exjade Average Price by Manufacturers (2019-2024)
2.4 Global Exjade Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Exjade, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Exjade, Product Type & Application
2.7 Exjade Market Competitive Situation and Trends
2.7.1 Exjade Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Exjade Players Market Share by Revenue
2.7.3 Global Exjade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Exjade Retrospective Market Scenario by Region
3.1 Global Exjade Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Exjade Global Exjade Sales by Region: 2019-2030
3.2.1 Global Exjade Sales by Region: 2019-2024
3.2.2 Global Exjade Sales by Region: 2025-2030
3.3 Global Exjade Global Exjade Revenue by Region: 2019-2030
3.3.1 Global Exjade Revenue by Region: 2019-2024
3.3.2 Global Exjade Revenue by Region: 2025-2030
3.4 North America Exjade Market Facts & Figures by Country
3.4.1 North America Exjade Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Exjade Sales by Country (2019-2030)
3.4.3 North America Exjade Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Exjade Market Facts & Figures by Country
3.5.1 Europe Exjade Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Exjade Sales by Country (2019-2030)
3.5.3 Europe Exjade Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Exjade Market Facts & Figures by Country
3.6.1 Asia Pacific Exjade Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Exjade Sales by Country (2019-2030)
3.6.3 Asia Pacific Exjade Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Exjade Market Facts & Figures by Country
3.7.1 Latin America Exjade Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Exjade Sales by Country (2019-2030)
3.7.3 Latin America Exjade Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Exjade Market Facts & Figures by Country
3.8.1 Middle East and Africa Exjade Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Exjade Sales by Country (2019-2030)
3.8.3 Middle East and Africa Exjade Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Exjade Sales by Type (2019-2030)
4.1.1 Global Exjade Sales by Type (2019-2024)
4.1.2 Global Exjade Sales by Type (2025-2030)
4.1.3 Global Exjade Sales Market Share by Type (2019-2030)
4.2 Global Exjade Revenue by Type (2019-2030)
4.2.1 Global Exjade Revenue by Type (2019-2024)
4.2.2 Global Exjade Revenue by Type (2025-2030)
4.2.3 Global Exjade Revenue Market Share by Type (2019-2030)
4.3 Global Exjade Price by Type (2019-2030)
5 Segment by Application
5.1 Global Exjade Sales by Application (2019-2030)
5.1.1 Global Exjade Sales by Application (2019-2024)
5.1.2 Global Exjade Sales by Application (2025-2030)
5.1.3 Global Exjade Sales Market Share by Application (2019-2030)
5.2 Global Exjade Revenue by Application (2019-2030)
5.2.1 Global Exjade Revenue by Application (2019-2024)
5.2.2 Global Exjade Revenue by Application (2025-2030)
5.2.3 Global Exjade Revenue Market Share by Application (2019-2030)
5.3 Global Exjade Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Exjade Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Exjade Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Exjade Industry Chain Analysis
7.2 Exjade Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Exjade Production Mode & Process
7.4 Exjade Sales and Marketing
7.4.1 Exjade Sales Channels
7.4.2 Exjade Distributors
7.5 Exjade Customers
8 Exjade Market Dynamics
8.1 Exjade Industry Trends
8.2 Exjade Market Drivers
8.3 Exjade Market Challenges
8.4 Exjade Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
